← PHIBRO ANIMAL HEALTH CORP PAHC
Market Price
$34.39
Market Cap
$1.38B
P/E Ratio
28.90
Revenue (FY 2025)
↑27.4% YoY
$1.30B
3-Yr CAGR: 11.2%
Net Income
↑1,897.7% YoY
$48.26M
Net Margin: 3.7%
Free Cash Flow
↓-9.8% YoY
$41.83M
FCF Yield: 3.03%
EPS (Diluted)
↑1,883.3% YoY
$1.19
Basic: $1.19
Return on Equity
Efficiency
16.9%
ROA: 6.0%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (PAHC)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $751.5M | — | $239.0M | $82.7M | — | $2.07 | — | $37.2M | $0.9M | — |
| FY 2017 | $764.3M | +1.7% | $248.2M | $64.6M | -21.9% | $1.61 | -22.2% | $98.4M | $77.5M | +8,849.8% |
| FY 2018 | $820.0M | +7.3% | $266.9M | $64.9M | +0.4% | $1.61 | 0.0% | $70.0M | $51.5M | -33.6% |
| FY 2019 | $828.0M | +1.0% | $264.6M | $54.7M | -15.7% | $1.35 | -16.1% | $47.2M | $17.3M | -66.4% |
| FY 2020 | $800.4M | -3.3% | $256.9M | $33.6M | -38.7% | $0.83 | -38.5% | $59.3M | $25.3M | +46.4% |
| FY 2021 | $833.4M | +4.1% | $271.4M | $54.4M | +62.1% | $1.34 | +61.4% | $48.3M | $19.0M | -25.0% |
| FY 2022 | $942.3M | +13.1% | $285.4M | $49.2M | -9.6% | $1.21 | -9.7% | $31.6M | $-5.4M | -128.4% |
| FY 2023 | $977.9M | +3.8% | $298.2M | $32.6M | -33.7% | $0.81 | -33.1% | $13.3M | $-38.5M | -613.3% |
| FY 2024 | $1,017.7M | +4.1% | $313.1M | $2.4M | -92.6% | $0.06 | -92.6% | $87.6M | $46.4M | +220.5% |
| FY 2025 | $1,296.2M | +27.4% | $399.9M | $48.3M | +1,897.7% | $1.19 | +1,883.3% | $80.1M | $41.8M | -9.8% |
Valuation
Market Price
$34.39
Market Cap
$1.38B
Enterprise Value
N/A
P/E Ratio
28.90
P/B Ratio
4.88
FCF Yield
3.03%
Dividend Yield
1.40%
Shares Outstanding
Profitability & Margins
Gross Margin
30.85%
Operating Margin
8.52%
Net Margin
3.72%
Return on Equity (ROE)
16.89%
Return on Assets (ROA)
5.95%
Asset Turnover
1.60x
Revenue 3-Yr CAGR
11.22%
Financial Health & Liquidity
Current Ratio
2.76
Cash Ratio
0.23
Debt / Equity
N/A
Debt / Assets
N/A
Cash & Equivalents
$68.04M
Total Debt
N/A
Book Value / Share
$7.04
Cash Flow Efficiency
Operating Cash Flow
$80.12M
Capital Expenditures (CapEx)
$38.29M
Free Cash Flow
$41.83M
OCF / Revenue
6.18%
FCF / Revenue
3.23%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
$1.19
EPS (Basic)
$1.19
Dividends / Share
$0.48
Book Value / Share
$7.04
EPS YoY Growth
1,883.33%
Balance Sheet (FY 2025)
Total Assets
$810.61M
Total Liabilities
$293.47M
Stockholders' Equity
$285.68M
Current Assets
$810.61M
Current Liabilities
$293.47M